COMMUNIQUÉS West-GlobeNewswire

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
09/12/2025
Expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the [...]
Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
09/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced that it intends to offer and sell $200 million of shares of its common stock and, in lieu of common [...]
Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy
09/12/2025
Clear recognition of high unmet need and urgency for the SCN2A community and plausibility of the mechanism of elsunersen FDA agreed to proposed changes to the EMBRAVE3 trial design to be a single-arm, baseline- [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
09/12/2025
ZUG, Switzerland, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company. Attachments Notification of managers' [...]
BillionToOne Reports Third Quarter 2025 Results
09/12/2025
MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
Sagimet Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/12/2025
SAN MATEO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Picard Celebrates Patient Living a World-Record of Over Eight Years with the SynCardia Total Artificial Heart
09/12/2025
-Picard Medical / SynCardia Systems LLC mark historic milestone as a patient reaches 2,900 days of continuous support with the SynCardia Total Artificial Heart -- the longest timeframe in the world ever recorded- TUCSON [...]
Medicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data
09/12/2025
TORONTO and HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of [...]
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
09/12/2025
SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
09/12/2025
– Financing includes leading U.S. biotechnology institutional investors and mutual funds – LOS ANGELES, CA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a [...]
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
10/12/2025
Key Opinion Leader, Dr. Ralph DeFronzo presents the “Future of Menin Inhibitors” and discusses icovamenib and its clinical results shared during WCIRDC 2025 in online interview SAN CARLOS, Calif., Dec. 09, 2025 (GLOBE [...]
Physician Health Programs Skirt the Americans with Disabilities Act, according to the Journal of American Physicians and Surgeons
09/12/2025
TUCSON, Ariz., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Physician Health Programs (PHPs) are supposed to help physicians with addiction problems recover, while protecting public safety. All too often, however, physicians are [...]
PathAI's AIM-MASH AI Assist¹ Becomes First AI-Powered Tool to Receive FDA Qualification for MASH Clinical Trials
09/12/2025
BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- PathAI , a global leader in AI-powered pathology, today announced that the U.S. Food and Drug Administration (FDA) has qualified AIM-MASH AI Assist through the Drug Development [...]
Natural Remedies Advances GutGard Research With New Study on Appetite and Metabolic Pathways
09/12/2025
BANGALORE, India, Dec. 09, 2025 (GLOBE NEWSWIRE) -- As consumers enter the holiday season and prepare for a new year focused on health, Natural Remedies announced that its patented digestive health ingredient GutGard® [...]
NADP Report Shows Continued Decline in Dental Benefits Enrollment
09/12/2025
Decreases Reflected in Commercially Insured and Government Funded Plans DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- According to the recently released 2025 Dental Benefits Report published annually by the National [...]
Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine
09/12/2025
WARREN, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), is proud to recognize Curtis Patton, PhD, founding member of Tevogen’s Board of Directors and Professor [...]
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
09/12/2025
Cloud-based platform combines AI and machine learning to perform multivariate analysis, enabling real-time optimization of cell therapy performance and patient outcomes SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09 [...]
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
09/12/2025
- First patient in the world treated with Alpha DaRT ® in the brain – - According to the National Brain Tumor Society, glioblastoma is one of the most complex, deadly, and treatment-resistant cancers, with an estimated [...]
Dandy Acquires Neem to Accelerate Digital Innovation in Dentistry
09/12/2025
Neem’s product, UX, and engineering talent will accelerate Dandy’s transformation of the chair-to-lab experience NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dandy , the dental technology company, today announced the [...]

Pages